BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10402213)

  • 1. Thromboxane receptors in human kidney tissues.
    Brown GP; Venuto RC
    Prostaglandins Other Lipid Mediat; 1999 Jun; 57(4):179-88. PubMed ID: 10402213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets.
    Folger WH; Halushka PV; Wilcox CS; Guzman NJ
    Eur J Pharmacol; 1992 Sep; 227(1):71-8. PubMed ID: 1426024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
    Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
    J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular thromboxane A2/prostaglandin H2 receptors: characterization and effect of adriamycin-induced nephrotic syndrome.
    Mayeux PR; Shah SV
    Biochim Biophys Acta; 1993 Apr; 1181(2):148-54. PubMed ID: 8481403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
    Masuda A; Mais DE; Oatis JE; Halushka PV
    Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the vascular thromboxane A2/prostaglandin endoperoxide receptor in rabbit aorta. Regulation by dexamethasone.
    Sessa WC; Halushka PV; Okwu A; Nasjletti A
    Circ Res; 1990 Dec; 67(6):1562-9. PubMed ID: 2147131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
    Dorn GW
    J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
    Pfister SL; Pratt PE; Kurian J; Campbell WB
    Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
    Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
    J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
    Dorn GW; Becker MW; Davis MG
    J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue- and species-specific differences in ligand binding to thromboxane A2 receptors.
    Dorn GW
    Am J Physiol; 1991 Jul; 261(1 Pt 2):R145-53. PubMed ID: 1830459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
    Johnson GJ; Leis LA; Dunlop PC
    J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational resistance to the pulmonary vasoconstrictor effect of the TxA2 mimetic U-46619: possible mechanism.
    Losonczy G; Brown G; Mucha I; Klocke R; Muller V; Merkely B; Tornoci L; Rosivall L; Venuto R
    Am J Physiol; 1997 Jun; 272(6 Pt 2):R1734-9. PubMed ID: 9227584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK; Mais DE; Halushka PV
    Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the prostanoid TP receptor population in human nonpregnant myometrium.
    Senchyna M; Crankshaw DJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):262-70. PubMed ID: 8859002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane A2 receptors in equine monocytes: identification of a new subclass of TXA2 receptors.
    Simmons TR; Cook JA; Moore JN; Halushka PV
    J Leukoc Biol; 1993 Feb; 53(2):173-8. PubMed ID: 8383167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of thromboxane receptor activation in rat glomerular mesangial cells.
    Spurney RF; Middleton JP; Raymond JR; Coffman TM
    Am J Physiol; 1994 Sep; 267(3 Pt 2):F467-78. PubMed ID: 8092261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane binding and signal transduction in rat glomerular mesangial cells.
    Spurney RF; Onorato JJ; Albers FJ; Coffman TM
    Am J Physiol; 1993 Feb; 264(2 Pt 2):F292-9. PubMed ID: 8447439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes.
    Dorn GW
    J Biol Chem; 1990 Mar; 265(8):4240-6. PubMed ID: 2137820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.